These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 4987468)

  • 1. [Resistance of Mycobacterium tuberculosis, the extent of isoniazid inactivation and blood bacteriostatic activity in chemotherapy of pulmonary tuberculosis].
    Tipp ZI
    Probl Tuberk; 1969; 47(8):76-9. PubMed ID: 4987468
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the lability of the degree of drug resistance of Mycobacterium tuberculosis strains].
    Belogurova VP
    Antibiotiki; 1967 Aug; 12(8):718-22. PubMed ID: 4968418
    [No Abstract]   [Full Text] [Related]  

  • 3. [Usefulness of rifampicin for pulmonary resection of drug-resistant pulmonary tuberculosis--report of the 13th series study. C].
    Kekkaku; 1973 Jan; 48(1):29-33. PubMed ID: 4632268
    [No Abstract]   [Full Text] [Related]  

  • 4. Course of cases of pulmonary tubercurosis with bacilli resistant to streptmycin, para-aminosalicylic acid and isoniazid and with multiple drug-resistance.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1969 Dec; 16(3):106-9. PubMed ID: 4988512
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phythyvazid-resistance of myobacterium tuberculosis and its clinical importance].
    Belogurova VP; Dargevich VK
    Sov Med; 1966 Mar; 29(3):66-72. PubMed ID: 4967965
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood bacteriostatic activity in patients with respiratory tuberculosis].
    Manicheva OA; Vishnevskiĭ BI; Ivanova LI; Pavlova MV; Archakova LI
    Probl Tuberk; 2001; (8):24-6. PubMed ID: 11767384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The importance of the inactivation of phthivazid in the mechanism of resistance to it in Mycobacterium tuberculosis].
    Smirnov AG
    Ter Arkh; 1966 Aug; 38(8):28-32. PubMed ID: 6011765
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of drug resistance and blood bacteriostatic activity in patients with pulmonary tuberculosis].
    Kochetov BI; Gur'ian IE
    Probl Tuberk; 1971; 49(6):64-7. PubMed ID: 5000745
    [No Abstract]   [Full Text] [Related]  

  • 9. [The epidemiologic significance of the resistance of tuberculosis mycobacteria to isonicotinic acid hydrazide].
    Margulis NIu; Vinogradova TI; Kusikova LM; Solomonova DE; Kerpel' RS
    Probl Tuberk; 1971 Oct; 49(10):12-5. PubMed ID: 5004988
    [No Abstract]   [Full Text] [Related]  

  • 10. Resistant mycobacterium tuberculosis: report of a family in Connecticut.
    Gerstenhaber BJ
    Conn Med; 1980 Jul; 44(7):416-8. PubMed ID: 6772373
    [No Abstract]   [Full Text] [Related]  

  • 11. Five cases of child tuberculosis caused by strains primarily resitant to all three main anti-tuberculosis drugs.
    Brander E; Aho K; Wasz-Höckert O
    Scand J Respir Dis; 1967; 48(1):76-80. PubMed ID: 4964559
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy of patients with chronic destructive pulmonary tuberculosis in cases of mycobacterial resistance to rifampicin and isoniazid].
    Bialik IB; Klimenko MT
    Klin Med (Mosk); 1985 Dec; 63(12):42-7. PubMed ID: 3937942
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary drug resistance. 3.
    Oka S; Matsuda T; Kobayashi T
    Sci Rep Res Inst Tohoku Univ Med; 1972 Nov; 19(3):103-5. PubMed ID: 4632285
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of emerging isoniazid resistance in Mycobacterium tuberculosis in Korea.
    Berliner DS; Haupt A
    Aviat Space Environ Med; 1987 Jan; 58(1):83-5. PubMed ID: 3101660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B; Pretet S
    Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monitoring of chemotherapy in patients with pulmonary tuberculosis by the blood bacteriostatic activity-determining test].
    Manicheva OA; Skvortsova LA; Pavlova MV; Sapozhnikova NV; Archakova LI; Vishnevskiĭ BI
    Probl Tuberk Bolezn Legk; 2008; (5):14-7. PubMed ID: 18711812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-resistance tuberculosis among the foreign-born in Canada.
    Can Commun Dis Rep; 2005 Feb; 31(4):46-52. PubMed ID: 15712449
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dynamics of drug resistance and restoration of sensitivity of Mycobacterium tuberculosis isolated from patients].
    Belogurova VP; Navrotskiĭ VV
    Antibiotiki; 1970 May; 15(5):434-7. PubMed ID: 4988018
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance of Mycobacterium tuberculosis to antituberculosis drugs in the Central Region of Thailand, 1996.
    Riantawan P; Punnotok J; Chaisuksuwan R; Pransujarit V
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):616-20. PubMed ID: 9712274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.